Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3165 of 6351
-
New drug combo targets Hard-to-Treat cancers with gene mutation
Disease control OngoingThe purpose of the study is to assess the safety and efficacy of inavolisib as a single-agent and in combination with atezolizumab in participants with phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PIK3CA)-mutated cancers, including previously tr…
Phase 1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Sleep drug may unlock Brain's natural garbage disposal
Knowledge-focused CompletedAlzheimer's disease is linked in part to the buildup of harmful proteins in the brain, including amyloid and tau. Most current treatments aim to remove these proteins directly. This study explores a different approach: helping the brain clear waste more effectively during sleep. …
Phase 1/2 • Sponsor: Applied Cognition • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Could a common painkiller boost emergency contraception for obese women?
Disease control CompletedThe goal of this clinical trial is to compare the delay in ovulation between placebo to levonorgestrel plus meloxicam in obese women with normal menses. The main questions it aims to answer are: 1. Ovulation will be delayed by ≥7 days following the first dose of levonorgestrel p…
Phase 2 • Sponsor: InnovaGyn, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a 3-Day test be enough for bladder device success?
Symptom relief Recruiting nowSacral neuromodulation (SNM) was approved by the Food and Drug Administration (FDA) for the treatment of urgency incontinence (UUI) in 1998. One of two trial phase techniques are utilized prior to placement of the implantable pulse generator (IPG) to predict a patient's success w…
Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New scan could spot liver danger before It's too late
Diagnosis Recruiting nowA total of fifty-five (55) patients with liver cirrhosis will be enrolled in this study to produce and validate dedicated Ga-PSMA-PET/MRI acquisition protocols. The specific hypotheses include: * Ga-PSMA PET/MRI may allow robust and reproducible noninvasive in vivo quantitation…
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
Texting to save lives: can a phone app get more black men screened for colon cancer?
Prevention CompletedThe goal of this clinical trial is to test a new smartphone-based program designed to help African American men get screened for colorectal cancer (CRC). The main question it aims to answer is: ° Are African American men who complete the smartphone-based program more likely to g…
Sponsor: ISA Associates, Inc. • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
New study sheds light on breast cancer in transgender community
Knowledge-focused CompletedThere is no granular retrospective data on breast cancer in transgender and gender-diverse (TGD) persons from a contemporary and diverse American cohort. The purpose of this investigation is to aggregate data from multiple institutions to describe the risk, diagnosis, management,…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Real-World italian study tracks vyxeos Liposomal's impact on Tough-to-Treat AML
Knowledge-focused CompletedThe study is a prospective, single-arm, non-experimental, observational study in patients in Italy with Acute Myeloid Leukaemia (AML) with myelodysplastic-related changes or therapy related AML initiating treatment with JZP351 (Vyxeos liposomal) in their normal clinical practice.
Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Your step count could reveal hidden health risks
Knowledge-focused Recruiting nowPhysical activity (PA) and sedentary lifestyle are determinants in the development of chronic diseases and associated quality of life alterations. PA levels are correlated with quality of life and morbidity in chronic lung disease (COPD), cardiovascular disease, diabetes, cancer,…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Simple breathing device may help lower blood pressure in obesity
Disease control OngoingThe purpose of this study is to determine whether inspiratory muscle strength training reduces blood pressure in adults with obesity.
Sponsor: Florida State University • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Fencing fights fatigue: new program aims to keep blood cancer patients moving
Symptom relief CompletedIn 20 years, the prognosis of hematology patients has improved thanks to the development and adaptation of treatments and better risk management. However, medium and long-term complications of intensive treatments are common and remain a real public health problem. Indeed, intens…
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Could a needle in the neck ease headache pain?
Disease control OngoingThis project comprises two studies; a cross-sectional study and a randomized controlled trial. 1. The goal of the cross-sectional study is to compare multiple outcome parameters in different headache types: tension type (TTH), cervicogenic (CGH) and myofascial headache (MFH) as …
Sponsor: University Ghent • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New combo therapy targets tough lymphoma in early trial
Disease control OngoingThe purpose of this study is to characterize safety and to determine the recommended phase 2 regimen (RP2R) for JNJ-87801493 in combination with T-cell engagers (TCEs) \[Part A: Dose Escalation\] and to further assess the safety of JNJ-87801493 at the RP2R in combination with TCE…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New pill shows promise for psoriasis in early trial
Disease control CompletedThe main purpose of this study is to determine the efficacy and safety of LY3972406 in adult participants with moderate-to-severe plaque psoriasis.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New mesh could improve pelvic surgery outcomes
Disease control Recruiting nowThis prospective study aims to assess the efficacy of the OviTex 1S permanent mesh in pelvic floor surgery in comparison with the current standard polypropylene mesh.
Sponsor: Meander Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New shot aims to stop Chemo's dangerous side effect
Disease control CompletedThe main aim of this clinical trial is to assess the safety and tolerability of PN20 in adult patients with chemotherapy-induced thrombocytopenia (CID). The main questions it aims to answer are: * Is PN20 safe in these patients? * Could these patients potentially benefit from PN…
Phase 1 • Sponsor: Chongqing Peg-Bio Biopharm Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Pre-Surgery brain boot camp aims to shield epilepsy patients from memory loss
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if new educational program prior to epilepsy surgery can either decrease the risk of cognitive decline after surgery or be a help to those patients who experience a decline after undergoing epilepsy surgery. Participants will participa…
Sponsor: Kayela Arrotta • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Phone coaching gets seniors moving after lung surgery
Symptom relief Recruiting nowThis clinical trial compares telephone-based physical activity coaching to self monitored physical activity for improving physical function in older adults who are undergoing surgery for lung cancer and their caregivers. Lung cancer surgery in older adults is associated with func…
Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New drug aims to heal hearts after attack – but trial halted early
Disease control Stopped earlyThis study is open to adults aged 18 and over who have just had a heart attack. The purpose of this study is to find out whether a medicine called BI 765845 helps people who have had a heart attack. The investigators also want to test how well different doses of BI 765845 work an…
Phase 2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Can a common diabetes drug help pancreatic cancer patients control blood sugar?
Disease control OngoingThe purpose of this study is to find out how effective and safe glipizide is for lowering blood sugar in people with pancreatic cancer.
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC